Skip to main content

West Virginia To Get $83M From Walgreens Over Opioid Crisis

West Virginia To Get $83M From Walgreens Over Opioid Crisis

West Virginia To Get $83M From Walgreens Over Opioid Crisis

Introduction

West Virginia reached an $83 million deal with Walgreens to end a lawsuit over the drugstore chain's participation in the state's opioid problem.

According to the state Attorney General, Walgreens has agreed to pay the compensation over an eight-year period. The proceeds from all opioid settlements will be dispersed in accordance with an agreement reached with the state and municipal governments on how to address the state's opioid issue.

According to the attorney general, the state will continue to pursue justice for those most affected by the opioid crisis. He said that while this and subsequent settlements will not bring back the lives lost due to the opioid epidemic; we hope that the money will give considerable assistance to people in West Virginia most affected by the issue.

The settlement ends a lawsuit alleging that the drugstore chain's failure to maintain adequate diversion controls contributed to the state's opioid oversupply.

Walgreens is a defendant in a class action lawsuit filed by Kroger, Walmart, CVS, and Rite Aid. Walmart and CVS reached a $147 million settlement with the state in September, while Rite Aid reached a $30 million settlement in August. Kroger is the only surviving defendant, and his trial is set for June.

Kroger is accused of failing to disclose questionable medication orders to the Drug Enforcement Administration and the West Virginia Board of Pharmacy, according to the attorney general.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!